BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23503722)

  • 1. Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer.
    Afzal S; Bojesen SE; Nordestgaard BG
    Clin Chem; 2013 May; 59(5):771-80. PubMed ID: 23503722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia.
    Afzal S; Bojesen SE; Nordestgaard BG
    Alzheimers Dement; 2014 May; 10(3):296-302. PubMed ID: 23871764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study.
    Afzal S; Nordestgaard BG; Bojesen SE
    J Invest Dermatol; 2013 Mar; 133(3):629-636. PubMed ID: 23190899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis.
    Brøndum-Jacobsen P; Nordestgaard BG; Schnohr P; Benn M
    Ann Neurol; 2013 Jan; 73(1):38-47. PubMed ID: 23225498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 25-Hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18,791 participants.
    Brøndum-Jacobsen P; Benn M; Tybjaerg-Hansen A; Nordestgaard BG
    J Thromb Haemost; 2013 Mar; 11(3):423-31. PubMed ID: 23279309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis.
    Afzal S; Bojesen SE; Nordestgaard BG
    Clin Chem; 2013 Feb; 59(2):381-91. PubMed ID: 23232064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies.
    Brøndum-Jacobsen P; Benn M; Jensen GB; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2794-802. PubMed ID: 22936341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 25-hydroxyvitamin D concentration and subsequent risk of total and site specific cancers in Japanese population: large case-cohort study within Japan Public Health Center-based Prospective Study cohort.
    Budhathoki S; Hidaka A; Yamaji T; Sawada N; Tanaka-Mizuno S; Kuchiba A; Charvat H; Goto A; Kojima S; Sudo N; Shimazu T; Sasazuki S; Inoue M; Tsugane S; Iwasaki M;
    BMJ; 2018 Mar; 360():k671. PubMed ID: 29514781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.
    Brøndum-Jacobsen P; Benn M; Afzal S; Nordestgaard BG
    Int J Epidemiol; 2015 Apr; 44(2):651-61. PubMed ID: 25981321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 Study.
    Cheney CP; Thorand B; Huth C; Berger K; Peters A; Seifert-Klauss V; Kiechle M; Strauch K; Quante AS
    Oncol Res Treat; 2018; 41(3):117-121. PubMed ID: 29485414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
    PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
    Schmutz EA; Zimmermann MB; Rohrmann S
    Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
    Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.
    McDonnell SL; Baggerly C; French CB; Baggerly LL; Garland CF; Gorham ED; Lappe JM; Heaney RP
    PLoS One; 2016; 11(4):e0152441. PubMed ID: 27049526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival.
    Weinstein SJ; Mondul AM; Yu K; Layne TM; Abnet CC; Freedman ND; Stolzenberg-Solomon RZ; Lim U; Gail MH; Albanes D
    Eur J Epidemiol; 2018 Nov; 33(11):1087-1099. PubMed ID: 30073448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort study.
    Ordóñez-Mena JM; Schöttker B; Haug U; Müller H; Köhrle J; Schomburg L; Holleczek B; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):905-16. PubMed ID: 23462913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease.
    Afzal S; Lange P; Bojesen SE; Freiberg JJ; Nordestgaard BG
    Thorax; 2014 Jan; 69(1):24-31. PubMed ID: 23908128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium.
    Ordóñez-Mena JM; Schöttker B; Fedirko V; Jenab M; Olsen A; Halkjær J; Kampman E; de Groot L; Jansen E; Bueno-de-Mesquita HB; Peeters PH; Siganos G; Wilsgaard T; Perna L; Holleczek B; Pettersson-Kymmer U; Orfanos P; Trichopoulou A; Boffetta P; Brenner H
    Eur J Epidemiol; 2016 Mar; 31(3):311-23. PubMed ID: 25977096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
    Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of serum vitamin D and cancer mortality in the United States.
    Freedman DM; Looker AC; Chang SC; Graubard BI
    J Natl Cancer Inst; 2007 Nov; 99(21):1594-602. PubMed ID: 17971526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.